XXXX : a rare case report and review of the literature.

@entity1 @entity3335 @entity548 @entity5 @entity8116 @entity1132 @entity3052 @entity11508 @entity1778 @entity8376 @entity2467 @entity236 @entity4585 @entity6961 @entity414
@entity4585 ( @entity4585 , @entity4585 , or extramedullary @entity5 ) is an extramedullary mass forming @entity5 composed of myeloid precursor cells. It is usually associated with @entity6961 but very rarely may precede the onset of @entity1778 . Here, we are presenting a rare case of primary vaginal @entity4585 in a geriatric female @entity1 without initial presentation of @entity3052 ( @entity3052 ). A 68-year-old female @entity1 with ECOG Performance Score of 1 presented with pervaginal @entity548 for 20 days. On colposcopic examination, she was found to have mass in the anterior fornix of vagina. A punch biopsy specimen revealed @entity8376 . @entity8116 ( @entity8116 ), @entity3335 ( @entity3335 ), and @entity2467 were strongly positive on IHC (immunohistochemistry). The @entity1 's routine blood investigations were normal including peripheral smear, @entity1132 dehydrogenase, @entity414 , 2D echocardiography, conventional cytogenetics, @entity236 , and biopsy. The @entity1 was given 4 cycles of @entity11508 (Decitex, manufactured by Sun Pharmaceutical Industries Limited, India), 20   mg/m(2) for 5 days at an interval of 28 days. There was a partial response to @entity11508 according to RECIST criteria. As @entity11508 therapy was well tolerated, we are continuing in the same way until disease progression without any complications. The @entity1 is undergoing regular follow-up at our centre.
